JPRN-UMIN000012640已完成未知
Observational study to assess dose-up efficacy of anticholinergic agent on nocturia in overactive bladder patients - Observational study to assess dose-up efficacy of anticholinergic agent on nocturia in overactive bladder patients(Dose Flex Study)
Clinical Research Support Center Kyushu0 个研究点目标入组 100 人开始时间: 2013年12月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with contraindications for imidafenacin 2)Patients who have current condition of severe difficulty of urination 3)Patients who have history of urinary retention 4)Patients with serious kidney dysfunction 5)Residual urine volume > 50 mL 6)Patients with cancer in bladder, cystoliths, urinary tract infection, recurrent urinary tract infection or interstitial cystitis 7)Patients with polyuria 8)Patients who have administered prohibited substances or done prohibited therapy in the 4 weeks prior to the start of study (excepting operations on urinary and sexual organs) 9)Patients who have been operated on the urinary or sexual organs in the 6 months prior to the start of study 10)Patients with unstable lower urinary tract symptoms 11)Any other patients who are regarded as unsuitable for this study by the investigator
研究者
相似试验
已完成
Unknown
A study to evaluate the dose-response efficacy of body fat reduction by continuous ingestion of test food. (SWE-2023-07-HCRINK)ot applicableJPRN-UMIN000051748Suntory Wellness Limited200
已完成
4 期
Intranasal ketamine for moderate to severe pain in children- a dose finding study.acute painmusculoskeletal injuryAnaesthesiology - Pain managementInjuries and Accidents - Other injuries and accidentsACTRN12612000012875Southern Health60
已完成
不适用
Clinical dose-finding study to assess the effect of ABAlifeTM on postprandial blood glucose profile in prediabetic subjects: randomized, multicentric, double-blind, placebo-controlled, cross-over study with different dosages combined with a 12-weeks follow-up phasePre-DiabetesDRKS00026093Anton Hübner GmbH & Co. KG61
终止
2 期
To identify the effective dose(s) of RT234 (vardenafil inhalation powder) to acutely improve pulmonary vascular haemodynamics in study participants with Pulmonary Arterial Hypertension (PAH).Cardiovascular - Other cardiovascular diseasesPulmonary Arterial HypertensionACTRN12619001178134Respira Therapeutics Australia Pty Ltd14
已完成
不适用
Verification of the efficacy and effective dose of dietary fibers on postprandial blood glucose elevatioHealthy adultsJPRN-UMIN000034771KAGOME CO., LTD.14